Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;29(6):639-644.
doi: 10.1097/BOR.0000000000000431.

Genetics in inclusion body myositis

Affiliations
Review

Genetics in inclusion body myositis

Simon Rothwell et al. Curr Opin Rheumatol. 2017 Nov.

Abstract

Purpose of review: To review the advances in our understanding of the genetics of inclusion body myositis (IBM) in the past year.

Recent findings: One large genetic association study focusing on immune-related genes in IBM has refined the association within the human leukocyte antigen (HLA) region to HLA-DRB1 alleles, and identified certain amino acid positions in HLA-DRB1 that may explain this risk. A suggestive association with CCR5 may indicate genetic overlap with other autoimmune diseases. Sequencing studies of candidate genes involved in related neuromuscular or neurodegenerative diseases have identified rare variants in VCP and SQSTM1. Proteomic studies of rimmed vacuoles in IBM and subsequent genetic analyses of candidate genes identified rare missense variants in FYCO1. Complex, large-scale mitochondrial deletions in cytochrome c oxidase-deficient muscle fibres expand our understanding of mitochondrial abnormalities in IBM.

Summary: The pathogenesis of IBM is likely multifactorial, including inflammatory and degenerative changes, and mitochondrial abnormalities. There has been considerable progress in our understanding of the genetic architecture of IBM, using complementary genetic approaches to investigate these different pathways.

PubMed Disclaimer

Figures

Box 1
Box 1
no caption available
FIGURE 1
FIGURE 1
Strategies for identifying genetic variants in IBM. Rare causal variants of high effect size are expected in Mendelian diseases such as hIBM. Genetic variants contributing to IBM susceptibility are expected to have a more modest effect size. Low-frequency variants of intermediate effect sizes will likely be found using sequencing studies. Common variants of low effect size will be detectable by well-powered genetic association studies. hIBM, hereditary IBM; IBM, body myositis.
FIGURE 2
FIGURE 2
A proposed model for the pathogenesis of IBM. Inflammation within muscle (Box 1) may induce fibre injury and HLA-I overexpression. Overloaded protein degradation systems (Box 2) induce misfolded protein deposits in muscle fibres. ER, endoplasmic reticulum; UPR, unfolded protein response. Figure adapted from [44].

References

    1. Needham M, Mastaglia FL. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 2007; 6:620–631. - PubMed
    1. Broccolini A, Mirabella M. Hereditary inclusion: body myopathies. Biochim Biophys Acta - Mol Basis Dis 2015; 1852:644–650. - PubMed
    1. Needham M, Mastaglia FL, Garlepp MJ. Genetics of inclusion: body myositis. Muscle Nerve 2007; 35:549–561. - PubMed
    1. Gang Q, Bettencourt C, Machado P, et al. Sporadic inclusion body myositis: the genetic contributions to the pathogenesis. Orphanet J Rare Dis 2014; 9:88. - PMC - PubMed
    1. Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012; 337:1190–1195. - PMC - PubMed

MeSH terms

Substances